Validated WES Assay for Biomarker Discovery and Clinical Development

biomarkers-adobestock_711623478

Validated whole exome sequencing workflows are essential for generating reliable genomic insights.

This scientific presentation examines a fully validated end-to-end whole exome sequencing (WES) workflow, from sample preparation and sequencing through bioinformatics analysis and quality control. Learn how standardized validation strategies and robust analytical performance support biomarker discovery, patient stratification, and translational research across multiple sample types.

Key topics include:

  • Validation of an end-to-end WES workflow for clinical research
  • Quality control strategies and bioinformatics best practices
  • Analytical performance, including sensitivity, specificity, precision, limit of detection, and matrix equivalency
  • Applications of validated WES for biomarker discovery, patient stratification, and translational research

As genomic technologies continue to advance, validated sequencing workflows are critical for generating high-quality, reproducible data. See how a comprehensive WES platform can support precision medicine and accelerate biomarker-driven clinical development.

Complete the form below to access this scientific presentation.

Validated WES Assay for Biomarker Discovery and Clinical Development

To learn more about how Eurofins processes and protects your personal data and your rights, please read our Privacy Notice.